Floatz logo

5-ala

Skin Neoplasms

DUSA Pharmaceuticals, Inc.Small moleculePhase 2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Skin Neoplasms cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4BB
TACROLIMUS
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4BB
Rapamycin
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4BB
Nivolumab
UNICANCER
Phase 2B
Difluoromethylornithine
University of Wisconsin, Madison
Phase 2B

View all 24 →

Same molecule, other indications

5-ala is also rated in:

brain neoplasmDormant
B
Indicative ·
61 / 100
View asset →
lentigo maligna melanomaDormant
B
Indicative ·
60 / 100
View asset →
glioblastomaDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →